The story of Viagra, and its creator copyright, presents a challenging case study for investors. Initially a blockbuster drug, yielding billions in income, its exclusivity period created a wave of lower-priced alternatives , significantly impacting its position . While specific pharmaceutical companies may try to capitalize on related treatments ,